Alignment Healthcare, Inc. (NASDAQ:ALHC) is currently under scrutiny by law firm Kaplan Fox & Kilsheimer LLP following a whistleblower complaint alleging accounting misconduct. A former executive claims the company misclassified millions in operating expenses as capital expenditures, inflating critical financial metrics. This revelation caused ALHC shares to drop significantly, sparking investor concerns over the reliability of the company’s previously reported financial data.

Key Points

• Alignment Healthcare, Inc. (NASDAQ:ALHC) is being investigated by Kaplan Fox & Kilsheimer LLP for possible securities law breaches.
• A whistleblower complaint by a former executive accuses the company of accounting irregularities that inflated reported and forecasted financial results, including Adjusted EBITDA.
• On July 8, 2026, ALHC stock declined $4.02 per share, or 16.7%, closing at $20.03 following the allegations.
• Kaplan Fox is seeking investors who experienced losses to assist in their investigation.

Whistleblower Alleges Misclassification Inflated ALHC’s Adjusted EBITDA

The whistleblower complaint, filed by a former Alignment Healthcare executive, alleges the company engaged in "accounting irregularities" that "artificially inflated" both reported and projected financial figures. The focus is on Adjusted EBITDA, a non-GAAP metric central to the company’s financial reporting and executive compensation. According to the complaint, "millions of dollars in operating expenses...

Read Full Story: https://news.google.com/rss/articles/CBMi4gFBVV95cUxOQTgtT2lsT0hnN3ZGckZNdHlx...